Adeshakin AO, Adeshakin FO, Yan D, Wan X. Regulating histone deacetylase signaling pathways of myeloid-derived suppressor cells enhanced T cell-based immunotherapy. Front Immunol. 2022;13:10.

Article  Google Scholar 

Ahuja P, Yadav R, Goyal S, Yadav C, Ranga S, & Kadian L. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches. Cell Biol Toxicol 2023;1–29. https://doi.org/10.1007/s10565-023-09818-5

Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8 T cells. Proc Natl Acad Sci. 2016;113(42):E6467–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhamarneh O, Stafford ND, Greenman J. IL10, An independent predictor of outcome in HNSCC patients. Otolaryngol Head Neck Surg. 2008;139(2_Suppl):P90.

Google Scholar 

Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017;8:561.

Article  PubMed  PubMed Central  Google Scholar 

Bae J, Hideshima T, Tai Y, Song Y, Richardson P, Raje N. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors. Leukemia. 2018;32(9):1932–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bally AP, Austin JW, Boss JM. Genetic and epigenetic regulation of PD-1 expression. J Immunol. 2016;196(6):2431–7.

Article  CAS  PubMed  Google Scholar 

Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682–7.

Article  CAS  PubMed  Google Scholar 

Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B. Epstein-Barr virus—associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies. Cancers. 2021;13(20):5189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhende PM, Seaman WT, Delecluse H, Kenney SC. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol. 2005;79(12):7338–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bossi P, Chan AT, Even C, Machiels J. ESMO–EURACAN clinical practice guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment for recurrent/metastatic disease. Ann Oncol. 2022;34(3):247–50. https://doi.org/10.1016/j.annonc.2022.11.011.

Article  CAS  PubMed  Google Scholar 

Burr ML, Sparbier CE, Chan KL, Chan Y, Kersbergen A, Lam EY. An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell. 2019;36(4):385-401.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buschle A, Hammerschmidt W. Epigenetic lifestyle of Epstein-Barr virus. Semin Immunopathol. 2020;42(2):131–42. https://doi.org/10.1007/s00281-020-00792-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao J, Yan Q. Cancer epigenetics, tumor immunity, and immunotherapy. Trends Cancer. 2020;6(7):580–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakravorty A, Sugden B, Johannsen EC. An epigenetic journey: Epstein-Barr virus transcribes chromatinized and subsequently unchromatinized templates during its lytic cycle. J Virol. 2019;93(8):2247.

Article  Google Scholar 

Chan AT, Tao Q, Robertson KD, Flinn IW, Mann RB, Klencke B. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. J Clin Oncol. 2004;22(8):1373–81.

Article  CAS  PubMed  Google Scholar 

Chang ET, Ye W, Zeng Y, Adami H. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2021;30(6):1035–47.

Article  CAS  Google Scholar 

Chau CM, Zhang X, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol. 2006;80(12):5723–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Martin KA, Lu F, Lupey LN, Mueller JM, Lieberman PM, Tempera I. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. J Virol. 2014;88(3):1703–13.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Chan AT, Le Q, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. The Lancet. 2019;394(10192):64–80.

Article  Google Scholar 

Chen Y, Zhou C, Li H, Li H, Li Y. Identifying key genes for nasopharyngeal carcinoma by prioritized consensus differentially expressed genes caused by aberrant methylation. J Cancer. 2021;12(3):874.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng T, Grasse L, Shah J, Chandra J. Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma. Drugs Today (Barcelona, Spain: 1998). 2015;51(8):491–504.

Article  CAS  Google Scholar 

Cheng J, Chen J, Xue K, Wang Z, Yu D. Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma. Cancer Cell Int. 2018;18(1):1–9.

Article  Google Scholar 

Chijioke O, Azzi T, Nadal D, Münz C. Innate immune responses against Epstein Barr virus infection. J Leukoc Biol. 2013;94(6):1185–90.

Article  PubMed  PubMed Central  Google Scholar 

Chow LK, Chung DL, Tao L, Chan KF, Tung SY, Ngan RKC. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. EBioMedicine. 2022;86:104357.

Article  Google Scholar 

Dai W, Cheung AKL, Ko JMY, Cheng Y, Zheng H, Ngan RKC. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma. Cancer Med. 2015;4(7):1079–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai W, Zheng H, Cheung AKL, & Lung ML. Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5(2):16. https://doi.org/10.21037/cco.2016.03.06

Darr CD, Mauser A, Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001;75(13):6135–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das D, Karthik N, Taneja R. Crosstalk between inflammatory signaling and methylation in cancer. Front Cell Dev Biol. 2021;9:756458.

Article  PubMed  PubMed Central  Google Scholar 

Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu Y. Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Investig. 2014;124(2):687–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding S, Gao Y, Lv D, Tao Y, Liu S, Chen C. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway. EBioMedicine. 2022;81:104100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunn J, Rao S. Epigenetics and immunotherapy: the current state of play. Mol Immunol. 2017;87:227–39.

Article  CAS  PubMed  Google Scholar 

Ekeuku SO, Etim EP, Pang K, Chin K, Mai C. Vitamin E in the management of pancreatic cancer: a scoping review. World J Gastrointest Oncol. 2023;15(6):943.

Article  PubMed  PubMed Central  Google Scholar 

Epstein MA. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1:702–3.

Article  CAS  PubMed  Google Scholar 

Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I. The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner. Pigment Cell Melanoma Res. 2019;32(5):687–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget. 2014;5(23):12189–202. https://doi.org/10.18632/oncotarget.2608.

Article  PubMed  PubMed Central  Google Scholar 

Frost TC, Gewurz BE. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship. Curr Opin Virol. 2018;32:15–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gailhouste L, Liew LC, Hatada I, Nakagama H, Ochiya T. Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells. Cell Death Dis. 2018;9(5):1–12.

Article  CAS